JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+4.92%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$155M
AUM Growth
+$155M
(-6.8%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-15.46%
Top 10 Holdings %
Top 10 Hldgs %
85.83%
Holding
74
New
19
Increased
15
Reduced
20
Closed
15
Top Buys
| 1 |
StoneCo
STNE
|
$17.7M |
| 2 |
XP
XP
|
$11.6M |
| 3 |
NGD
New Gold Inc
NGD
|
$6.5M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$4.34M |
| 5 |
Inter&Co
INTR
|
$1.31M |
Top Sells
| 1 |
Boyd Gaming
BYD
|
$64.3M |
| 2 |
Nu Holdings
NU
|
$18.1M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$6.99M |
| 4 |
Sigma Lithium
SGML
|
$5.86M |
| 5 |
VanEck Gold Miners ETF
GDX
|
$667K |
Sector Composition
| 1 | Financials | 32.73% |
| 2 | Healthcare | 12.7% |
| 3 | Technology | 11.38% |
| 4 | Materials | 4.47% |
| 5 | Energy | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
XP
XP
$9.56B
| $29.9M | 19.21% | 1,165,000 +451,836 | +63% | +$11.6M |
|
|
2
StoneCo
STNE
$4.41B
| $17.7M | 11.38% | +1,065,700 | New | +$17.7M |
|
|
3
Nu Holdings
NU
$71.5B
| $17.4M | 11.19% | 1,460,000 -1,517,959 | -51% | -$18.1M |
|
|
NGD
4
New Gold Inc
NGD
$4.67B
| $6.5M | 4.18% | +3,823,527 | New | +$6.5M |
|
|
5
Rhythm Pharmaceuticals
RYTM
$6.85B
| $4.58M | 2.95% | 105,814 +100,126 | +1,760% | +$4.34M |
|
6
Incyte
INCY
$16.5B
| $1.79M | 1.15% | 31,440 +134 | +0.4% | +$7.63K |
|
7
Eli Lilly
LLY
$657B
| $1.69M | 1.09% | 2,177 -162 | -7% | -$126K |
|
|
ONC
8
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.64M | 1.05% | 10,471 +626 | +6% | +$97.9K |
|
|
9
Inter&Co
INTR
$3.78B
| $1.31M | 0.84% | +229,172 | New | +$1.31M |
|
10
S&P Global
SPGI
$167B
| $1.28M | 0.82% | 3,000 +1,900 | +173% | +$808K |
|
11
UnitedHealth
UNH
$281B
| $1.2M | 0.77% | 2,430 -696 | -22% | -$344K |
|
12
Thermo Fisher Scientific
TMO
$186B
| $816K | 0.52% | 1,404 -469 | -25% | -$273K |
|
13
Intuitive Surgical
ISRG
$170B
| $712K | 0.46% | 1,785 -361 | -17% | -$144K |
|
14
Acadia Pharmaceuticals
ACAD
$4.38B
| $680K | 0.44% | 36,755 +645 | +2% | +$11.9K |
|
|
15
VanEck Gold Miners ETF
GDX
$19B
| $667K | 0.43% | 21,093 -21,091 | -50% | -$667K |
|
16
Merck
MRK
$210B
| $667K | 0.43% | 5,053 -1,122 | -18% | -$148K |
|
17
Elevance Health
ELV
$71.8B
| $614K | 0.39% | 1,184 -5 | -0.4% | -$2.59K |
|
18
Stryker
SYK
$150B
| $612K | 0.39% | 1,709 -95 | -5% | -$34K |
|
19
Jacobs Solutions
J
$17.5B
| $556K | 0.36% | 3,616 +1,632 | +82% | +$251K |
|
20
YPF
YPF
$12B
| $495K | 0.32% | +25,000 | New | +$495K |
|
21
Danaher
DHR
$147B
| $470K | 0.3% | 1,883 -936 | -33% | -$234K |
|
22
Vertex Pharmaceuticals
VRTX
$100B
| $442K | 0.28% | 1,058 -434 | -29% | -$181K |
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $369K | 0.24% | 4,225 +1,093 | +35% | +$95.5K |
|
24
Madrigal Pharmaceuticals
MDGL
$9.76B
| $356K | 0.23% | 1,333 +28 | +2% | +$7.48K |
|
25
argenx
ARGX
$43.6B
| $353K | 0.23% | 896 -100 | -10% | -$39.4K |
|